Use of diabetic-related liver-derived secretory protein for diagnosis or treatment of type 2 diabetes or vascular disorders

摘要

Providing the use of selenoprotein P for the diagnosis or treatment of type 2 diabetes or vascular disorders. A method of detecting type 2 diabetes or vascular disorder comprising measuring selenoprotein P, a method of assessing the risk of suffering from type 2 diabetes or vascular disorder, a method of assessing insulin resistance or glycemic control in a subject, and A therapeutic agent for type 2 diabetes or vascular disorder targeting selenoprotein P.